Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Crazy About Vascular Solutions, Inc. (VASC)

Page 1 of 2

There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Carl Icahn and George Soros think. Those hedge fund operators make billions of dollars each year by hiring the best and the brightest to do research on stocks, including small cap stocks that big brokerage houses simply don’t cover. Because of Carl Icahn and other successful funds’ exemplary historical records, we pay attention to their small cap picks. In this article, we use hedge fund filing data to analyze Vascular Solutions, Inc. (NASDAQ:VASC).

Vascular Solutions, Inc. (NASDAQ:VASC) has experienced an increase in activity from the world’s largest hedge funds lately. VASC was in 10 hedge funds’ portfolios at the end of the third quarter of 2016. There were 8 hedge funds in our database with VASC positions at the end of the previous quarter. At the end of this article we will also compare VASC to other stocks including Fox Factory Holding Corp (NASDAQ:FOXF), SPX Corporation (NYSE:SPXC), and Wingstop Inc (NASDAQ:WING) to get a better sense of its popularity.

Follow Vascular Solutions Inc (NASDAQ:VASC)
Trade (NASDAQ:VASC) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

hxdbzxy/Shutterstock.com

hxdbzxy/Shutterstock.com

What does the smart money think about Vascular Solutions, Inc. (NASDAQ:VASC)?

At Q3’s end, a total of 10 of the hedge funds tracked by Insider Monkey were long this stock, a gain of 25% from one quarter earlier. On the other hand, there were a total of 12 hedge funds with a bullish position in VASC at the beginning of this year. So, let’s check out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

13
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Renaissance Technologies, one of the largest hedge funds in the world, holds the most valuable position in Vascular Solutions, Inc. (NASDAQ:VASC). Renaissance Technologies has a $15.8 million position in the stock. On Renaissance Technologies’ heels is GAMCO Investors, led by Mario Gabelli, which holds a $10 million position. Other hedge funds and institutional investors that hold long positions encompass Richard Driehaus’ Driehaus Capital, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, and Paul Hondros’ AlphaOne Capital Partners. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.

Page 1 of 2